•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.11,187 Merck & Co., Inc. $MRK Shares Purchased by Allianz SE
Merck & Co., Inc. $MRK Stake Reduced by Barrow Hanley Mewhinney & Strauss LLC
1 High-Flying Stock to Buy Hand Over Fist if the Stock Market Crashes
Merck Reports Positive Survival Data For Investigational Therapy for Advanced Gastric Cancer
HALO Faces Legal Setback in Germany Over MRK's Keytruda SC, Stock Down
Merck's drug prolongs survival in advanced stomach, esophageal cancers in trial
Halozyme Stock Slides, European Patent Fight With Merck Spurs Fresh Pressure
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Merck & Co., Inc. (MRK) Presents at Jefferies London Healthcare Conference Transcript
Merck & Co. Eyes Kidney Cancer Data as Vaccine Research Expands Beyond Melanoma
Merck and Isomorphic Labs Enter Strategic Research Collaboration
Insider Selling: Merck & Co., Inc. (NYSE:MRK) EVP Sells $8,611,961.85 in Stock
Bristol Myers vs. Merck: Which Big Pharma Stock Is the Better Buy?
Merck Ends Nemtabrutinib Development: What's Next for Its Pipeline?
Thomas H. Glocer to Retire From Merck Board of Directors in May 2027; Douglas M. Baker, Jr. Appointed Independent Lead Director
Merck stops trials of blood cancer drug after risk assessment
Merck Announces Update on BELLWAVE Clinical Development Program Evaluating Nemtabrutinib
Merck Announces First-Quarter 2027 Dividend
Forget SCHD: 4 Dividend Stocks Retirees Should Own Instead
Merck & Co., Inc. (NYSE:MRK) Share Price Breaks Below Fifty Day Moving Average Following Insider Selling